Key facts
- Invesco Ltd. filed SCHEDULE 13G/A for Collegium Pharmaceutical Inc Common Stock (COLL).
- Disclosed ownership: 4.9%.
- Date of event: 30 Jun 2025.
Invesco Ltd. - 30 Jun 2025 SCHEDULE 13G/A Report for Collegium Pharmaceutical Inc Common Stock (COLL)
- Filing Manager
- Invesco Ltd.
- Reporting Manager
- Invesco Ltd.
- Symbol
- COLL
- Shares outstanding
- 32,344,306 shares
- Disclosed Ownership
- 1,584,871 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Aug 2025, 16:27:45 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 07 Feb 2025
- Next filing
- 08 May 2026
- SEC
- View on sec.gov
Key filing fact
Invesco Ltd. disclosed 4.9% ownership in Collegium Pharmaceutical Inc Common Stock (COLL) on 30 Jun 2025.
Change
- Previous schedule filing date: 07 Feb 2025.
- Current filing was accepted on 07 Aug 2025, 16:27.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Invesco Ltd. | 4.9% | 1,584,871 | 1,460,375 | 0 | Robert R. Leveille | Global Head of Compliance |
CIK / CUSIP context first